Ensuring access to innovative medicines for the population is a key objective, recognized at both the European level[1] and at the national level[2], acting as a genuine impetus for national authorities to develop a legal framework that is equally properly aligned with this aim. However,
Pentru a putea fi decontate în România, prețurile maximale ale medicamentelor care se eliberează pe bază de prescripție medicală trebuie să fie aprobate de Ministerul Sănătății. Ministerul Sănătăţii aprobă preţul maximal de producător, preţul maximal cu ridicata şi preţul maximal cu amănuntul. În prezent, modul de
Disease awareness campaigns are not advertisement to medicines Advertisement to medicines can be performed under strictly regulated conditions. Advertisement to RX (i.e., medicines released based on medical prescription) to the general public is prohibited, while advertisement to OTC (i.e., over-the-counter medicines) may be performed while observing
Diversification of trade relations in the pharmaceutical field led to a non-unitary practice of national authorities regarding the interpretation and application of regulations for import of medicines. Although there are uniform rules at EU level which describe the minimum standard and conditions that an importer